Established in the year 2000 as a Biocon subsidiary, Clinigene became India's first CAP (College of American Pathologists) accredited Central Laboratory. Clinigene's services now span a broad spectrum of activities including human pharmacology, bioanalytical research, central laboratory, clinical operations, medical writing, medical monitoring, safety management, pharmacovigilance, clinical data management & biostatistics and regulatory services supporting early-phase through late-phase clinical development programs. We have extensive working knowledge of a wide range of products such as biologics, biotechnology products, vaccines, devices and small molecules. All activities are carried out in strict compliance with regulatory and ICH GCP requirements.

Our comprehensive investigator database and expertise in various therapeutic areas like Diabetology, Oncology, Cardiology, Neuropsychiatry, Nephrology, Immunology, Rheumatology, Infectious diseases and Gastroenterology give us significant leverage in providing faster patient recruitment, cost competitive trials, yet world-class clinical support. Quick turnaround time and personalized attention to customer needs sets us apart from our peers. Conforming to the highest standards of ethics, patients under investigation are assured of their rights, safety and confidentiality.

With India emerging as a credible destination for conducting global clinical trials, Clinigene is positioned for dynamic growth. Our proven scientific excellence together with full-scale clinical research capabilities enable us to undertake and deliver challenging studies for our global as well as local partners.